Summary
Estrogens are vital female hormones, but their use in therapy and contraception can cause liver damage. This review examines estrogen mechanisms, liver risks, and influencing factors.
Area of Science:
- Endocrinology
- Hepatology
- Pharmacology
Background:
- Estrogens are critical hormones for female reproductive health.
- Therapeutic applications include hormone replacement, contraception, and treating hormone-dependent diseases.
- Estrogen therapy carries potential risks, particularly hepatotoxicity.
Purpose of the Study:
- To elucidate the mechanisms of estrogen action.
- To investigate the potential hepatotoxic effects of estrogens.
- To identify risk factors and inter-agent differences in estrogen-induced liver injury.
Main Methods:
- Review of existing literature on estrogen pharmacology and toxicology.
- Analysis of mechanisms underlying estrogen metabolism and signaling.
- Examination of clinical data and experimental studies on estrogen hepatotoxicity.
Main Results:
- Estrogens exert diverse effects through nuclear and membrane receptors.
- Hepatotoxicity can manifest through various mechanisms including oxidative stress and inflammation.
- Risk factors include dose, duration of exposure, and individual susceptibility.
Conclusions:
- Understanding estrogen mechanisms is crucial for mitigating liver risks.
- Further research is needed to differentiate hepatotoxic potential among various estrogen compounds.
- Clinical use of estrogens requires careful risk-benefit assessment regarding liver health.
More Related Videos
Related Concept Videos
01:30Liver Physiology
415
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
415
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
526
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
526
01:19Factors Affecting Drug Biotransformation: Biological
105
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
105
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
132
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
132
01:09Hepatic Drug Clearance: Effect of Protein Binding
146
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
146